The United States has launched a formal trade investigation into Germany’s proposed reforms aimed at reducing public spending on pharmaceuticals, amid concerns in Washington that the
measures could unfairly disadvantage American drug makers.
U.S. Trade Representative Jamieson Greer announced on Thursday that the inquiry will examine whether Germany’s policy direction is “unreasonable or discriminatory” under Section 301 of the Trade Act of 1974. The mechanism allows the U.S. to investigate and potentially respond to foreign practices deemed harmful to American commerce.
As part of the process, the Office of the U.S. Trade Representative will open a public docket for written submissions on June 25, followed by a Section 301 Committee hearing scheduled for September.
“I am particularly concerned with news that Germany is fast-tracking legislation that would further reduce its spending on innovative pharmaceuticals,” Greer said.
The investigation comes after Germany revealed plans in April to overhaul its statutory healthcare system in an effort to close a projected €20 billion ($23 billion) funding gap. The proposed reforms included variable discounts on prescription drugs, though they are now reportedly being revised following pushback from the pharmaceutical industry.
A German government source told Reuters that the original proposal is being reconsidered after opposition from industry stakeholders.
The probe adds to a broader pattern of trade actions under Washington’s current approach. Since returning to office last year, U.S. President Donald Trump has pursued an assertive trade agenda, including new global tariffs and threats of additional levies on multiple trading partners.
Earlier this month, the administration proposed tariffs of up to 12.5% on imports from 60 countries following a separate Section 301 review concerning forced labor in supply chains.
The outcome of the Germany investigation could pave the way for potential tariff measures on German exports, depending on the findings of the review. Photo by German Embassy Germany.info, Wikimedia commons.
